3Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.Arch Intern Med,1991,151:933-938.
5Urokinase Pulmonary embolism trial: a national cooperative study. Circulation ,1973, 47:1-108.
6Goldhaber SZ, Kessler CM, Heit J, et al.Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.Lancet,1988,2:293-298.
7Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism.Chest,1992,101(4 Suppl):183S-185S.
8Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol, 1997,80:184-188.
9Arcasoy SM, Kreit JW.Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence.Chest,1999,115:1695-1707.
6Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology guideline : recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin 0ncol.2007.25:5490-5505.
7Davis FM, Woolner DF, Frampton C, et al. Prospective, multi- centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth, 1987,59 : 1080- 1088.
8Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J,2008,29:2276-2315.
9Scholz KH, Hilmer T, Schuster S, et al. Thrombolysis in resuscitated patients with pulomonary embolism. I)tsch Med Wochenschr, 1990,115:930-935.
10Janata K, Holzer M, Kurkciyan I, et al. Major bleeding complications in eardinpulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation ,2003,57:49-55.
